NYSE: JNJ
Johnson & Johnson Stock

JNJ Price
$137.19
Fair Value Price
N/A
Market Cap
$361.20B
52 Week Low
$111.14
52 Week High
$155.51
P/E
21.24x
P/B
5.6x
P/S
4.74x
PEG
1.43x
Dividend Yield
2.86%%
Revenue
$80.86B
Earnings
$16.99B
Gross Profit Margin
65.7%%
Operating Margin
23.83%%
Net Profit Margin
21%%
Debt to Equity
1.65
Operating Cash Flow
$22B
Beta
0.67
Next Earnings
N/A
Ex-Dividend
Nov 23, 2020
Next Dividend
Dec 8, 2020

Zen Score

High
Medium
Low
53
Industry average

Reasons for this score

JNJ ($137.19) is trading below its intrinsic value of $420.30, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
JNJ is good value based on its earnings relative to its share price (21.24x), compared to the US market average 46.84x)
Valuation
JNJ is good value based on its earnings relative to its share price (21.24x), compared to the US Drug Manufacturers - General industry average (-11.04x)
Valuation

1 of 13

JNJ News

Valuation

JNJ price to earnings (PE)

For valuing profitable companies with steady earnings
Company
21.24x
Industry
-11.04x
Market
46.84x
JNJ is good value based on its earnings relative to its share price (21.24x), compared to the US market average 46.84x)
Valuation
JNJ is good value based on its earnings relative to its share price (21.24x), compared to the US Drug Manufacturers - General industry average (-11.04x)
Valuation

JNJ price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.6x
Industry
7.13x
Market
63.22x
JNJ is good value based on its book value relative to its share price (5.6x), compared to the US market average (63.22x)
Valuation
JNJ is good value based on its book value relative to its share price (5.6x), compared to the US Drug Manufacturers - General industry average (7.13x)
Valuation

JNJ price to earnings growth (PEG)

For valuing profitable companies with growth potential
JNJ is poor value relative to its rate of earnings growth, measured by PEG ratio (1.43x)
Valuation

JNJ's financial health

Profit margin

Revenue
$20.7B
Net Income
$5.8B
Profit Margin
28%%
JNJ's Earnings (EBIT) of $19.27B can safely cover interest payments on company debt ($37.76B)
Financials
JNJ's profit margin has increased (+3.7%%) in the last year from (17.3%%) to (21%%)
Financials

Assets to liabilities

Assets
$155.0B
Liabilities
$93.7B
Debt to equity
0.45
JNJ's short-term assets ($57.58B) exceed its short-term liabilities ($38.85B)
Financials
JNJ's long-term liabilities ($67.37B) exceed its short-term assets ($57.58B)
Financials
JNJ's debt has increased relative to shareholder equity (1.65), over the past 5 years ago (0.86)
Financials
JNJ's debt to equity ratio (1.65) is considered high
Financials

Cash flow

Operating
$3.4B
Investing
-$581.0M
Financing
-$4.3B
JNJ's operating cash flow ($21.59B) is sufficient to service the company's debt ($37.76B)
Financials

Johnson & Johnson Stock FAQ

(NYSE: JNJ) Johnson & Johnson trades on the NYSE under the ticker symbol JNJ. Johnson & Johnson stock quotes can also be displayed as NYSE: JNJ.
(NYSE: JNJ) Johnson & Johnson stock price per share is $137.19 today (as of Oct 29, 2020).
(NYSE: JNJ) Johnson & Johnson's 52-week high was $155.51, and its 52-week low was $111.14. It is currently -11.78%% from its 52-week high and 23.44%% from its 52-week low.
(NYSE: JNJ) Johnson & Johnson's market cap is $361.20B, as of Oct 30, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Johnson & Johnson's market cap is calculated by multiplying JNJ's current stock price of $137.19 by JNJ's total outstanding shares of 2,632,823,475.
(NYSE: JNJ) Johnson & Johnson currently has 2,632,823,475 outstanding shares. With Johnson & Johnson stock trading at $137.19 per share, the total value of Johnson & Johnson stock (market capitalization) is $361.20B.

Johnson & Johnson stock was originally listed at a price of $32.94 in Dec 31, 1997. If you had invested in Johnson & Johnson stock at $32.94, your return over the last 22 years would have been 316.48%%, for an annualized return of 6.7%%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics